Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure

DOI: 10.4254/wjh.v11.i1.65

Keywords: Hepatitis B, Hepatocellular carcinoma, Antiviral therapy, Persistent Risk for hepatocellular carcinoma, Tumor ablation

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text